United States Antimony vs Versamet Royalties
United States Antimony and Versamet Royalties are similar in size: $39.3m and $34.8m of revenue in their latest fiscal years. Versamet Royalties grew faster (189.1% against 162.8%). Versamet Royalties kept more of each dollar of sales as profit: a net margin of 58.5% against -11.1%. Versamet Royalties carries less debt relative to equity (0.0% against 0.1%).
| Latest fiscal year | United States AntimonyUAMY, 2025 | Versamet RoyaltiesVMET, 2025 |
|---|---|---|
| Revenue | $39.3m | $34.8m |
| Revenue growth | 162.8% | 189.1% |
| Net income | −$4.3m | $20.3m |
| Operating margin | -21.5% | 111.5% |
| Net margin | -11.1% | 58.5% |
| Return on equity | -5.1% | 9.1% |
| Free cash flow | −$37.5m | — |
| Cash | $30.5m | $3.7m |
| Total debt | $195,425 | $0 |
| Debt to equity | 0.1% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $449,475 | — |
| Employees | 100 | — |
| Market value | $430m | $818m |
| Price vs our value range | — | — |
| Moat score | 22 (Weak) | — |
| Insider trades, 12 months | 5 buys, 0 sales | 0 buys, 0 sales |